Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours Β· Estimated delivery Aug 7 - Aug 12
Safe medication mixing supports patient trust in clinical treatment processes
Removal from Category 2 does not render these bulk drug substances eligible for compounding under section 503A
Notes: Our recommended vendor supplies BPC-157/TB-500 capsules in 60-day containers, which represents a 60-day supply per test subject
Sciatic nerve crush models in rodents have been used to study peripheral nerve regeneration, and several papers have reported findings suggesting accelerated functional recovery and improved axonal integrity in BPC-157-treated animals compared to controls
US$ 23.13
US$ 27.59
US$ 29.00
US$ 27.57
